Often referred to as the “silent killer,” ovarian cancer does not become symptomatic for many women until a late stage of the disease. So any advance that shifts detection earlier, and allows physicians to intervene when survival remains potentially longer, can be welcome news. Sylvester researcher Brian Slomovitz, M.D., and colleagues are conducting a biomarker study to improve early detection, and survival.
Researchers from Sylvester Comprehensive Cancer Center and Bascom Palmer Eye Institute at the University of Miami Miller School of Medicine have uncovered evidence that genomic aberrations in uveal melanoma that lead to metastasis may occur far earlier in tumor evolution than previously believed. The findings fundamentally change the thinking about how this eye cancer progresses.
The Global Oncology Initiative encourages researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine to develop innovative and cost-effective ways to control and treat cancer in low resource countries. Ambitious inaugural proposals from three young researchers serve as prime examples.
There could be new hope for people diagnosed with glioma. An enzyme inhibitor in development can control the cancer and reduce the tumor growth rate by as much as 50 percent, according to a Phase I clinical trial conducted by researchers at Sylvester Comprehensive Cancer Center and other institutions. The results are particularly striking because the 66 patients in the study failed to completely respond to previous treatments.
A surgical oncologist at Sylvester Comprehensive Cancer Center of the University of Miami Miller School of Medicine has found that a simple procedure dramatically reduces lymphedema, a long-term swelling of the arm, after the removal of lymph nodes in breast cancer patients. This technique “lowers the rate of lymphedema from nearly one in five patients to just 3 percent.” said Eli Avisar, M.D.
A team of researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine has obtained promising results with patients who have acute myeloid leukemia that has not responded well to prior standard treatments. Acute myeloid leukemia is a blood cancer characterized by rapid growth of abnormal white blood cells most commonly found in older patients.
As part of the Florida Firefighter Cancer Initiative, experts at Sylvester Comprehensive Cancer Center examined survey responses from 2,399 firefighters statewide about cancer and prevention practices. The findings were published as a Research Letter online in the Journal of the American Medical Association (JAMA) Dermatology.
Thirty years ago, Marlene Berg founded Cancer Link with a small group of women to increase awareness of breast cancer and raise funds for research. Since then, the all-volunteer nonprofit has raised nearly $3 million to support Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine. “We are all grateful for the great care provided by Sylvester’s medical team," said Berg.
At the dedication ceremony held November 18, 2016, for The Lennar Foundation Medical Center — the gleaming five-story, 206,000-square foot state-of-the-art outpatient facility constructed by UHealth-the University of Miami Health System on the Coral Gables campus — speakers described a new vision for health care.
Jessica MacIntyre, M.S.N., ARNP, director of clinical operations for the Office of the Director at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, was honored at the South Florida Hispanic Chamber of Commerce’s 2017 Women Empowering and Embracing Women awards program on December 1. She received the “Inspiring and Achieving Award” for her work in health care.